Circulating IL-6 and survival outcomes in renal cell carcinoma: a systematic review and meta-analysis. Arch Ital Urol Androl [Internet]. 2025 Sep. 30 [cited 2026 Jun. 22];97(3). Available from: https://www.pagepressjournals.org/aiua/article/view/13955